Literature DB >> 17434462

Akt up- and down-regulation in response to endoplasmic reticulum stress.

Toru Hosoi1, Kanae Hyoda, Yasunobu Okuma, Yasuyuki Nomura, Koichiro Ozawa.   

Abstract

Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of CNS diseases such as Alzheimer's disease, Parkinson's disease, and cerebral ischemia. In the present study, we found that Akt activation is regulated dually by ER stress in primary cultured glial cells. We observed that Akt activation was increased by short-term exposure to ER stress but was down-regulated by long-term exposure to ER stress. ER stress-induced Akt activation was mediated through phosphatidylinositol 3-kinase (PI3K) because the PI3K inhibitors, LY294002 and wortmannin, inhibited Akt activation. Moreover, Akt was localized in the ER, as assessed by immunohistochemistry, and ER stress increased microsomally localized Akt activation. These results suggest that Akt plays an important role in stress conditions, which impair ER function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434462     DOI: 10.1016/j.brainres.2007.03.052

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  35 in total

1.  Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.

Authors:  Shiuan Wey; Biquan Luo; Chun-Chih Tseng; Min Ni; Hui Zhou; Yong Fu; Deepa Bhojwani; William L Carroll; Amy S Lee
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

2.  Akt determines cell fate through inhibition of the PERK-eIF2α phosphorylation pathway.

Authors:  Zineb Mounir; Jothi Latha Krishnamoorthy; Shuo Wang; Barbara Papadopoulou; Shirley Campbell; William J Muller; Maria Hatzoglou; Antonis E Koromilas
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

3.  Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.

Authors:  Alessia Di Nardo; Ioannis Kramvis; Namjik Cho; Abbey Sadowski; Lynsey Meikle; David J Kwiatkowski; Mustafa Sahin
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

4.  Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response.

Authors:  Hiroaki Yamazaki; Nobuhiko Hiramatsu; Kunihiro Hayakawa; Yasuhiro Tagawa; Maro Okamura; Ryouji Ogata; Tao Huang; Shotaro Nakajima; Jian Yao; Adrienne W Paton; James C Paton; Masanori Kitamura
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment.

Authors:  Lloyd A Greene; Oren Levy; Cristina Malagelada
Journal:  Cell Mol Neurobiol       Date:  2011-03-10       Impact factor: 5.046

Review 6.  Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies.

Authors:  Kunyu Shen; David W Johnson; David A Vesey; Michael A McGuckin; Glenda C Gobe
Journal:  Cell Stress Chaperones       Date:  2017-09-27       Impact factor: 3.667

7.  A unique modulator of endoplasmic reticulum stress-signalling pathways: the novel pharmacological properties of amiloride in glial cells.

Authors:  Toru Hosoi; Ayaka Kume; Kayo Otani; Tatsuya Oba; Koichiro Ozawa
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

8.  GIV/Girdin promotes cell survival during endoplasmic reticulum stress.

Authors:  Peter Nguyen; Rosanna Calderon; Yoanna Rodriguez-Ledezma; Kelly Araujo; Deepali Bhandari
Journal:  Mol Cell Biochem       Date:  2018-08-25       Impact factor: 3.396

9.  Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells.

Authors:  Ansgar Brüning; Klaus Friese; Alexander Burges; Ioannis Mylonas
Journal:  Breast Cancer Res       Date:  2010-07-01       Impact factor: 6.466

10.  Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice.

Authors:  Tracie A Seimon; Yibin Wang; Seongah Han; Takafumi Senokuchi; Dorien M Schrijvers; George Kuriakose; Alan R Tall; Ira A Tabas
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.